-
cds.ahrq.gov/sites/default/files/workgroups/1261/CDS_Connect_WG_%20March2021_%20Summary.pdf
March 18, 2021 - CDS Connect Work Group Meeting Summary 3-18-2021
CDS (Clinical Decision Support) Connect Work Group
Meeting Summary
March 18, 2021
3:00 – 4:00 pm ET
Attendees: 49 people (43 attendees + 6 call-ins)
Organization Attendee Names
AHRQ Members Steve Bernstein, Roland Gamache, Ed Lomotan, Mary Nix, Mari…
-
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
January 01, 2021 - CDS Connect Work Group June 2021 Summary
CDS (Clinical Decision Support) Connect Work Group
Meeting Summary
June 17, 2021
3:00-4:00 pm ET
Attendees: 41 people, including 3 phone dial-ins
Organization Attendee Names
AHRQ Sponsors Edwin Lomotan; Mario Teran; Roland Gamache; Steve Bernstein (4)
Work Group…
-
cds.ahrq.gov/sites/default/files/workgroups/236/may-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
05/09/2017
Time
5:00 – 7:00 PM EST
AGENDA
· Welcome
· Gather Feedback on Lookback Periods, Notifications for the USPSTF Artifacts and Value Sets
· CDS Connect Pilot Overview
· Statin CDS Demos: Options for Providing CDS Notifications
· Next Ste…
-
cds.ahrq.gov/sites/default/files/workgroups/33746/CDS_Connect_WG_Presentation_September_2021.pdf
January 01, 2021 - CDS Connect September 2021 Work Group Meeting
September 2021 CDS Connect Work Group Call
Meeting Agenda
Schedule Topic
3:00 – 3:02 • Roll Call, Allie Rabinowitz (MITRE)
3:02 – 3:05 • Review of the Agenda, Maria Michaels (CDC)
3:05 – 3:50 • Discussion:
CDS Connect Key Updates September 2020-21 (MITRE)
3:50 – …
-
cds.ahrq.gov/disclaimer
April 06, 2025 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_Intervention_Content_T2DM_Part_Two_Counseling.xlsx
January 01, 2023 - This link to their Quality Guidelines provides additional information on how resources are reviewed and
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Pilot Goals and Scope
The primary goals of the pilot were to: (1) translate evidence-based clinical guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
January 01, 2019 - Pilot Goals and Scope
The primary goals of the pilot were to: (1) translate evidence-based clinical guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Pilot Goals and Scope
The primary goals of the pilot were to: (1) translate evidence-based clinical guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Pilot Goals and Scope
The primary goals of the pilot were to: (1) translate evidence-based clinical guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Pilot Goals and Scope
The primary goals of the pilot were to: (1) translate evidence-based clinical guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Pilot Goals and Scope
The primary goals of the pilot were to: (1) translate evidence-based clinical guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - This tool uses data value sets informed by the Center for Communicable Diseases (CDC) Guidelines for
-
cds.ahrq.gov/sites/default/files/cds/artifact/27811/Test-Cases.xlsx
October 28, 2021 - recommendation given no no give recommendation for preferred Step 4 therapy; low-dose ICS-LABA + LAMA is not c/w guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
October 28, 2021 - recommendation given no no give recommendation for preferred Step 4 therapy; low-dose ICS-LABA + LAMA is not c/w guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/27796/Test-Cases.xlsx
October 28, 2021 - recommendation given no no give recommendation for preferred Step 4 therapy; low-dose ICS-LABA + LAMA is not c/w guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/27781/Test-Cases.xlsx
October 28, 2021 - recommendation given no no give recommendation for preferred Step 4 therapy; low-dose ICS-LABA + LAMA is not c/w guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/27806/Test-Cases.xlsx
October 28, 2021 - recommendation given no no give recommendation for preferred Step 4 therapy; low-dose ICS-LABA + LAMA is not c/w guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/27816/Test-Cases.xlsx
October 28, 2021 - recommendation given no no give recommendation for preferred Step 4 therapy; low-dose ICS-LABA + LAMA is not c/w guidelines
-
cds.ahrq.gov/sites/default/files/cds/artifact/27771/Test-Cases.xlsx
October 28, 2021 - recommendation given no no give recommendation for preferred Step 4 therapy; low-dose ICS-LABA + LAMA is not c/w guidelines